Analysts at B. Riley started coverage on shares of Senseonics Holdings Inc (AMEX:SENS) in a research report issued to clients and investors on Tuesday. The brokerage set a “buy” rating and a $5.50 price target on the stock. B. Riley’s target price would indicate a potential upside of 45.12% from the company’s previous close.

Senseonics Holdings (AMEX:SENS) opened at 3.79 on Tuesday. The company’s market capitalization is $353.94 million. The stock has a 50 day moving average of $3.99 and a 200-day moving average of $3.58. Senseonics Holdings has a 52-week low of $2.53 and a 52-week high of $4.24.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.